about
Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinomaSuccinct guide to liver transplantation for medical studentsManagement of early hepatic artery occlusion after liver transplantation with failed rescueImaging Cytometry of Human Leukocytes with Third Harmonic Generation Microscopy.Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis.14-3-3σ induces heat shock protein 70 expression in hepatocellular carcinoma.C1GALT1 promotes invasive phenotypes of hepatocellular carcinoma cells by modulating integrin β1 glycosylation and activity14-3-3ε overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma.Perturbations in ataxia telangiectasia mutant signaling pathways after drug-induced acute liver failure and their reversal during rescue of animals by cell therapyUp-regulation of microRNA-190b plays a role for decreased IGF-1 that induces insulin resistance in human hepatocellular carcinoma.Dimerumic acid inhibits SW620 cell invasion by attenuating H₂O₂-mediated MMP-7 expression via JNK/C-Jun and ERK/C-Fos activation in an AP-1-dependent manner.Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signalingManagement of hepatic angiomyolipoma.Long-Term Outcomes of Patients with Acute Cholecystitis after Successful Percutaneous Cholecystostomy Treatment and the Risk Factors for Recurrence: A Decade Experience at a Single Center.Long-term survival in patients with T2 hepatocellular carcinoma after primary curative resection can be further stratified by tumor size.Post-transplant malignancy in liver transplantation: a single center experienceProtection against acetaminophen-induced acute liver failure by omentum adipose tissue derived stem cells through the mediation of Nrf2 and cytochrome P450 expressionc-Maf regulates pluripotency genes, proliferation/self-renewal, and lineage commitment in ROS-mediated senescence of human mesenchymal stem cells.Diaphragmatic injury caused by an endo-retractor during laparoscopic cholecystectomy.Hepatic preconditioning for transplanted cell engraftment and proliferation.Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor.Persistent elevation of hepatocyte growth factor activator inhibitors in cholangiopathies affects liver fibrosis and differentiation.Effects of Monascus-fermented rice extract on malignant cell-associated neovascularization and intravasation determined using the chicken embryo chorioallantoic membrane model.Pancreatic carcinoma cells stimulate proliferation and matrix synthesis of hepatic stellate cells.Successful Living-Donor Liver Transplant for Fulminant Hepatitis in a Heart Recipient.Clinical course of de novo hepatitis B infection after pediatric liver transplantation.A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy.Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy: comparative effectiveness of treatment modalities.Lipocalin-2 gene expression during liver regeneration after partial hepatectomy in rats.C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization.Isolated increase in serum alkaline phosphatase after liver transplantation: risk factors and outcomes analysis.Hepatocyte-Like Cells Derived From Mouse Induced Pluripotent Stem Cells Produce Functional Coagulation Factor IX in a Hemophilia B Mouse Model.Hepatocyte transplantation and drug-induced perturbations in liver cell compartments.Serine protease hepsin regulates hepatocyte size and hemodynamic retention of tumor cells by hepatocyte growth factor signaling in mice.Education of imaging. Hepatobiliary and pancreatic: biliary stent causing imminent duodenal perforation.Revisiting donor risk over two decades of single-center experience: More attention on the impact of overweight.Survey Results of the Expert Meeting on Laparoscopic Living Donor Hepatectomy and Literature Review.Expert Panel Statement on Laparoscopic Living Donor Hepatectomy.Clinical feasibility of Gd-EOB-DTPA-enhanced MR imaging for assessing liver function: validation with ICG tests and parenchymal cell volume.Robotic-assisted minimally invasive liver resection.
P50
Q28073769-BA94F1A6-D6B6-402B-81A8-C3A737ABB6E7Q28075352-76EB926A-7350-4B42-9837-5FE16BCA462CQ28084028-7D78B222-744F-4CF6-8142-3150450AA091Q30828629-D0A2EBA1-C583-4C7E-AED5-C76B1CC36FA8Q33687809-F7B42491-407A-4AC7-826A-02B6703EF2D9Q33769256-142265E1-CCCA-407C-B65E-29FEA50F36CFQ33999174-D72E6A79-A519-4D3C-A541-AEBFA3841C21Q34618508-307ACC09-F98F-4A54-AC3C-F6EBDB43EF2FQ34755843-3B6688FC-AEAC-4036-9243-332C164B7823Q35107341-D9E4A153-0C83-4F60-9C75-04C4A328A4F6Q35144719-AB3EFC5C-E820-4033-9D70-3FC66AC7944CQ35742375-583D6B21-DD74-46B8-BC13-6D033E264C17Q35751535-8B9544AA-56B2-47C7-BA75-AC854095D061Q35907291-F711C050-0759-4BE6-BC35-F26D5A459777Q36152525-FE13D501-23B2-43F0-BFB2-790C2F283F23Q36154140-B04568EE-A73A-4DDB-B7D1-C3D9F3993024Q36476000-3D0AD19B-48EE-43BE-8937-BEB8822A36B7Q36546379-33E1816C-D61A-4FB1-AC35-A6E45267F77DQ36561060-FBBBB706-60DE-4CD6-AB7C-3F51648A4EC4Q37355060-D2DA056E-4EA2-4C1C-B428-315948D751D8Q39459644-6004B0F1-D7EC-441E-8CF2-2682BF9F4322Q39478341-AFA4306D-D643-4803-8AF6-0DFA6E948547Q39720374-41079695-D965-41EE-994A-6DC0D4C78ED3Q39847771-8EF6D255-0C21-46D0-B516-3445E68EF48FQ42230152-B6A5D756-3E92-462B-AB84-B7776C860CDBQ43928776-9C828AFF-2854-4D07-BC72-FDFFDB88A333Q44681461-0A6A24DA-40E6-4109-8E31-B43C557405A4Q44761898-8C9E6529-619E-4280-B427-91957A349044Q44781102-18229E50-A4DD-4304-B087-062BA5575EDCQ45158681-F41A4D83-E44E-48B2-845C-FCBA0839C408Q45242677-49AF2C56-1773-4D70-A920-6B81A830B7E7Q45879431-2192E82D-DABD-4687-A009-BC0AD200FDDEQ46952220-8B48541C-D8C0-4027-856A-300D21781C87Q47315721-7F1B19BC-CD90-476B-A7B5-9CE574E29E06Q47774671-D1227B4E-A8B0-461E-8E7F-EC6A98251951Q49898531-0F60B432-F392-4A12-A0C1-63E1605AE0CBQ50069928-EFF0F52C-C20D-4CB5-8E90-FF855B1EC23AQ50097324-ECDBECCF-F77B-4CA7-AD03-755CD1E9AB24Q50225614-634A7E6D-6A9B-4111-9996-1E23A6393A4FQ51101263-9376D672-3082-4D11-B342-96FF4C2F45B9
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Yao-Ming Wu
@ast
Yao-Ming Wu
@en
Yao-Ming Wu
@es
Yao-Ming Wu
@nl
type
label
Yao-Ming Wu
@ast
Yao-Ming Wu
@en
Yao-Ming Wu
@es
Yao-Ming Wu
@nl
prefLabel
Yao-Ming Wu
@ast
Yao-Ming Wu
@en
Yao-Ming Wu
@es
Yao-Ming Wu
@nl
P106
P1153
8265304000
P31
P496
0000-0002-1720-7863